583 related articles for article (PubMed ID: 20231499)
41. Clinical services provided by interventional radiologists to Medicare beneficiaries in the United States, 2000-2003.
Khan N; Murphy TP; Soares GM; Zahir IS
J Vasc Interv Radiol; 2005 Dec; 16(12):1753-7. PubMed ID: 16371546
[TBL] [Abstract][Full Text] [Related]
42. Cost of nonmelanoma skin cancer treatment in the United States.
Chen JG; Fleischer AB; Smith ED; Kancler C; Goldman ND; Williford PM; Feldman SR
Dermatol Surg; 2001 Dec; 27(12):1035-8. PubMed ID: 11849266
[TBL] [Abstract][Full Text] [Related]
43. Skin cancer is among the most costly of all cancers to treat for the Medicare population.
Housman TS; Feldman SR; Williford PM; Fleischer AB; Goldman ND; Acostamadiedo JM; Chen GJ
J Am Acad Dermatol; 2003 Mar; 48(3):425-9. PubMed ID: 12637924
[TBL] [Abstract][Full Text] [Related]
44. The period prevalence and costs of treating nonmelanoma skin cancers in patients over 65 years of age covered by medicare.
Joseph AK; Mark TL; Mueller C
Dermatol Surg; 2001 Nov; 27(11):955-9. PubMed ID: 11737130
[TBL] [Abstract][Full Text] [Related]
45. The incidence of skin cancer in dermatology.
van der Geer S; Siemerink M; Reijers HA; Verhaegh ME; Ostertag JU; Neumann HA; Krekels GA
Clin Exp Dermatol; 2013 Oct; 38(7):724-9. PubMed ID: 24073653
[TBL] [Abstract][Full Text] [Related]
46. Chronic condition mortality in the Medicare population.
Krause KJ; Bloom T
J Insur Med; 2012; 43(3):145-53. PubMed ID: 23451615
[TBL] [Abstract][Full Text] [Related]
47. An updated assessment of utilization of interventional pain management techniques in the Medicare population: 2000 - 2013.
Manchikanti L; Pampati V; Falco FJ; Hirsch JA
Pain Physician; 2015; 18(2):E115-27. PubMed ID: 25794210
[TBL] [Abstract][Full Text] [Related]
48. Geographic variation in the utilization of noninvasive diagnostic imaging: national medicare data, 1998-2007.
Parker L; Levin DC; Frangos A; Rao VM
AJR Am J Roentgenol; 2010 Apr; 194(4):1034-9. PubMed ID: 20308507
[TBL] [Abstract][Full Text] [Related]
49. Temporal trends in healthcare utilization following primary melanoma diagnosis among Medicare beneficiaries.
Lott JP; Wang Q; Titus LJ; Onega T; Nelson HD; Weinstock MA; Elmore JG; Tosteson ANA
Br J Dermatol; 2017 Sep; 177(3):845-853. PubMed ID: 28369774
[TBL] [Abstract][Full Text] [Related]
50. Temporal and Geographic Variation in the Incidence of Alzheimer's Disease Diagnosis in the US between 2007 and 2014.
Kirson NY; Meadows ES; Desai U; Smith BP; Cheung HC; Zuckerman P; Matthews BR
J Am Geriatr Soc; 2020 Feb; 68(2):346-353. PubMed ID: 31797361
[TBL] [Abstract][Full Text] [Related]
51. Age distribution of patients with advanced non-melanoma skin cancer in the United States.
Dacosta Byfield S; Chen D; Yim YM; Reyes C
Arch Dermatol Res; 2013 Nov; 305(9):845-50. PubMed ID: 23604961
[TBL] [Abstract][Full Text] [Related]
52. Percutaneous adhesiolysis procedures in the medicare population: analysis of utilization and growth patterns from 2000 to 2011.
Manchikanti L; Helm Ii S; Pampati V; Racz GB
Pain Physician; 2014; 17(2):E129-39. PubMed ID: 24658484
[TBL] [Abstract][Full Text] [Related]
53. Surgical treatment of nonmelanoma skin cancer in the Medicare population.
Manternach T; Housman TS; Williford PM; Teuschler H; Fleischer AB; Feldman SR; Chen GJ
Dermatol Surg; 2003 Dec; 29(12):1167-9; discussion 1169. PubMed ID: 14725656
[TBL] [Abstract][Full Text] [Related]
54. Determination of lung cancer incidence in the elderly using Medicare claims data.
McBean AM; Babish JD; Warren JL
Am J Epidemiol; 1993 Jan; 137(2):226-34. PubMed ID: 8452127
[TBL] [Abstract][Full Text] [Related]
55. Skin biopsy utilization and melanoma incidence among Medicare beneficiaries.
Weinstock MA; Lott JP; Wang Q; Titus LJ; Onega T; Nelson HD; Pearson L; Piepkorn M; Barnhill RL; Elmore JG; Tosteson ANA
Br J Dermatol; 2017 Apr; 176(4):949-954. PubMed ID: 27639256
[TBL] [Abstract][Full Text] [Related]
56. Physician specialty cost differences of treating nonmelanoma skin cancer.
Chirikov VV; Stuart B; Zuckerman IH; Christy MR
Ann Plast Surg; 2015 Jan; 74(1):93-9. PubMed ID: 24503881
[TBL] [Abstract][Full Text] [Related]
57. Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011.
Guy GP; Machlin SR; Ekwueme DU; Yabroff KR
Am J Prev Med; 2015 Feb; 48(2):183-187. PubMed ID: 25442229
[TBL] [Abstract][Full Text] [Related]
58. Evaluating Access to Eye Care in the Contiguous United States by Calculated Driving Time in the United States Medicare Population.
Lee CS; Morris A; Van Gelder RN; Lee AY
Ophthalmology; 2016 Dec; 123(12):2456-2461. PubMed ID: 27633646
[TBL] [Abstract][Full Text] [Related]
59. Coding multiple diagnoses for patient visits at which procedures were performed: no evidence for abuse by physicians.
Feldman SR; Fleischer AB; Shaffer CL; Kiang SH; Williford PM; Lupton FA; Chen GJ
Dermatol Surg; 2003 Feb; 29(2):150-4. PubMed ID: 12562344
[TBL] [Abstract][Full Text] [Related]
60. Surveillance in a time of changing health care practices: estimating ectopic pregnancy incidence in the United States.
Zane SB; Kieke BA; Kendrick JS; Bruce C
Matern Child Health J; 2002 Dec; 6(4):227-36. PubMed ID: 12512764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
